Perspective Therapeutics (CATX) Accumulated Depreciation & Amortization (2011 - 2026)

Perspective Therapeutics' Accumulated Depreciation & Amortization history runs 16 years deep, the most recent figure standing at $7.3 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization rose 98.59% year-over-year to $7.3 million; the TTM figure through Mar 2026 stood at $7.3 million (up 98.59% YoY), while the FY2025 annual figure was $6.2 million, up 109.59% from the prior year.
• Accumulated Depreciation & Amortization came in at $7.3 million for Q1 2026 at Perspective Therapeutics, up from $6.2 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $8.3 million in Q3 2023 to a low of $15000.0 in Q4 2022.
• A 5-year average of $4.8 million and a median of $5.2 million in 2025 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization sank 99.8% in 2022 and soared 4360.0% in 2023, its largest moves.
• Perspective Therapeutics' Accumulated Depreciation & Amortization stood at $15000.0 in 2022, then jumped by 4360.0% to $669000.0 in 2023, then jumped by 342.45% to $3.0 million in 2024, then soared by 109.59% to $6.2 million in 2025, then rose by 18.12% to $7.3 million in 2026.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $7.3 million, $6.2 million, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison